checkAd

    DGAP-Adhoc  436  0 Kommentare WILEX AG plans rights issue using authorised capital





    DGAP-Ad-hoc: WILEX AG / Key word(s): Capital Increase


    WILEX AG plans rights issue using authorised capital


    24-Apr-2017 / 10:01 CET/CEST


    Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG.


    The issuer is solely responsible for the content of this announcement.



    Ad-hoc release - Insider information pursuant to Article 17 MAR



    - Not for distribution, publication or transmission in the USA, Canada, Japan and Australia -



    WILEX AG plans rights issue using authorised capital



    Munich, Germany, 24 April 2017 - The Executive Management Board of WILEX AG (ISIN DE000A11QVV0 / WL6 / FSE) today resolved, with the approval of the Supervisory Board, to increase the Company's share capital using authorized capital from EUR 12,927,564.00 by up to EUR 2,040,816.00 to up to EUR 14,968,380.00 by issuing up to 2,040,816 new no-par value shares with a notional value of EUR 1.00 each and full entitlement to dividends effective 1 December 2016 in return for cash contributions.



    The new shares (ISIN DE000A2E4SX4 / WKN A2E / 4SX) will be offered exclusively to shareholders at a 19:3 ratio by means of an indirect subscription right by Baader Bank AG, Unterschleissheim. Shareholders will therefore be entitled to subscribe for 3 new shares for each 19 existing shares held. In order to ensure an even subscription ratio, one shareholder waived its subscription rights from 2,396 old shares.



    The subscription period will begin on 26 April 2017 at 0:00 am CET and will end on 10 May 2017 at 02:00 pm CET. The subscription price is fixed at EUR 2.45. There will be no organized trading in subscription rights.



    Any new shares not subscribed for as a result of the offer may be purchased by shareholders only - also at the subscription price - as part of an additional subscription for shares. Binding offers for such additional subscriptions must be submitted within the subscription period.



    The main shareholder, dievini Hopp BioTech holding GmbH & Co. KG, Walldorf, Germany, has agreed to exercise its subscription rights and take over new shares not subscribed as part of the offer to exercise subscription and additional subscription rights.

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-Adhoc WILEX AG plans rights issue using authorised capital DGAP-Ad-hoc: WILEX AG / Key word(s): Capital Increase WILEX AG plans rights issue using authorised capital 24-Apr-2017 / 10:01 CET/CEST Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The …

    Schreibe Deinen Kommentar

    Disclaimer